The host environment regulates the function of CD8+ graft-versus-host-reactive effector cells

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 6820-6828

  Chakraverty, Ronjon ^a   Flutter, Barry ^a   Fallah Arani, Farnaz ^a   Eom, Hyeon Seok ^b,c   Means, Terry ^b   Andreola, Giovanna ^b   Schwarte, Sebastian ^b   Buchli, Jennifer ^a   Cotter, Pete ^b   Zhao, Guiling ^b   Sykes, Megan ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOCOMPATIBILITY; HOST; INFLAMMATION; IRRADIATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; ANIMAL; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; LYMPHOCYTE ACTIVATION; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA;

EID: 58149191879     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.6820     Document Type: Article

References (45)

1. Weiden, P. L., K. M. Sullivan, N. Flournoy, R. Storb, and E. D. Thomas. 1981. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med. 304: 1529-1533.
2. Weiden, P. L., N. Flournoy, E. D. Thomas, R. Prentice, A. Fefer, C. D. Buckner, and R. Storb. 1979. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 300: 1068-1073.
3. Billiau, A. D., S. Fevery, O. Rutgeerts, W. Landuyt, and M. Waer. 2002. Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants. Blood 100: 1894-1902.
4. Xia, G., R. L. Truitt, and B. D. Johnson. 2006. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. Biol. Blood Marrow Transplant. 12: 397-407. (Pubitemid 43380956)
5. + antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions. Blood 108: 2106-2113.
6. Mapara, M. Y., Y. M. Kim, J. Marx, and M. Sykes. 2003. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus- leukemia effects after conversion to full donor chimerism. Transplantation 76: 297-305.
7. Mapara, M. Y., Y. M. Kim, S. P. Wang, R. Bronson, D. H. Sachs, and M. Sykes. 2002. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 100: 1903-1909.
8. Chakraverty, R., D. Cote, J. Buchli, P. Cotter, R. Hsu, G. Zhao, T. Sachs, C. M. Pitsillides, R. Bronson, T. Means, et al. 2006. An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J. Exp. Med. 203: 2021-2031. (Pubitemid 44188475)
9. Cooke, K. R., A. Gerbitz, J. M. Crawford, T. Teshima, G. R. Hill, A. Tesolin, D. P. Rossignol, and J. L. Ferrara. 2001. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J. Clin. Invest. 107: 1581-1589.
10. Guy-Grand, D., and P. Vassalli. 1986. Gut injury in mouse graft-versus-host reaction: study of its occurrence and mechanisms. J. Clin. Invest. 77: 1584-1595. (Pubitemid 16047103)
11. Hill, G. R., J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L. Ferrara. 1997. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90: 3204-3213. (Pubitemid 27444217)
12. McCarthy, P. L., Jr., S. Abhyankar, S. Neben, G. Newman, C. Sieff, R. C. Thompson, S. J. Burakoff, and J. L. Ferrara. 1991. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood 78: 1915-1918.
13. Nestel, F. P., K. S. Price, T. A. Seemayer, and W. S. Lapp. 1992. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor α during graft-versus-host disease. J. Exp. Med. 175: 405-413.
14. Piguet, P. F., G. E. Grau, B. Allet, and P. Vassalli. 1987. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J. Exp. Med. 166: 1280-1289.
15. Johnson, B. D., and R. L. Truitt. 1995. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. Blood 85: 3302-3312.
16. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336: 73-76. (Pubitemid 18262137)
17. Sykes, M., Z. Bukhari, and D. H. Sachs. 1989. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation. Bone Marrow Transplant. 4: 465-474. (Pubitemid 19236576)
18. + T cell activity. J. Immunol. 150: 197-205.
19. + cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects. Blood 83: 2560-2569.
20. Kranz, D. M., S. Tonegawa, and H. N. Eisen. 1984. Attachment of an antireceptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 81: 7922-7926.
21. Abdi, R., T. K. Means, and A. D. Luster. 2003. Chemokines in islet allograft rejection. Diabetes Metab. Res. Rev. 19: 186-190.
22. Barber, D. L., E. J. Wherry, and R. Ahmed. 2003. Cutting edge: Rapid in vivo killing by memory CD8 T cells. J. Immunol. 171: 27-31.
23. Yang, Y. G., J. J. Sergio, D. A. Pearson, G. L. Szot, A. Shimizu, and M. Sykes. 1997. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood 90: 4651-4660.
24. Yang, Y. G., J. Qi, M. G. Wang, and M. Sykes. 2002. Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells. Blood 99: 4207-4215.
25. Dey, B., Y. G. Yang, F. Preffer, A. Shimizu, K. Swenson, D. Dombkowski, and M. Sykes. 1999. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model. Transplantation 68: 141-149. (Pubitemid 29352845)
26. Blazar, B. R., C. J. Lees, P. J. Martin, R. J. Noelle, B. Kwon, W. Murphy, and P. A. Taylor. 2000. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. J. Immunol. 165: 4901-4909.
27. Gonzalez, M., S. A. Quezada, B. R. Blazar, A. Panoskaltsis-Mortari, A. Y. Rudensky, and R. J. Noelle. 2002. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. J. Immunol. 169: 5581-5589. (Pubitemid 35291657)
28. Johnson, B. D., E. E. Becker, J. L. LaBelle, and R. L. Truitt. 1999. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. J. Immunol. 163: 6479-6487.
29. + immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol. Blood Marrow Transplant. 8: 525-535.
30. Young, K. J., B. DuTemple, M. J. Phillips, and L. Zhang. 2003. Inhibition of graft-versus-host disease by double-negative regulatory T cells. J. Immunol. 171: 134-141. (Pubitemid 36745281)
31. + early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions. Blood 102: 740-748.
32. Xun, C. Q., J. S. Thompson, C. D. Jennings, S. A. Brown, and M. B. Widmer. 1994. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 83: 2360-2367. (Pubitemid 24112752)
33. + T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109: 1335-1344.
34. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11: 748-756.
35. Marzo, A. L., H. Yagita, and L. Lefrançois. 2007. Cutting edge: Migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells. J. Immunol. 179: 36-40.
36. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411. (Pubitemid 36278597)
37. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
38. + T cells requires CD154 expression by Th cells in acute graft versus host disease. J. Immunol. 162: 4373-4376.
39. + memory T cells. Nature 441: 890-893.
40. Kolb, H. J., C. Schmid, A. J. Barrett, and D. J. Schendel. 2004. Graft-versus-leukemia reactions in allogeneic chimeras. Blood 103: 767-776.
41. + T cells. Immunity 22: 259-270.
42. Zeng, D., P. Hoffmann, F. Lan, P. Huie, J. Higgins, and S. Strober. 2002. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood 99: 1449-1457. (Pubitemid 34547104)
43. Bastianutto, C., A. Mian, J. Symes, J. Mocanu, N. Alajez, G. Sleep, W. Shi, A. Keating, M. Crump, M. Gospodarowicz, et al. 2007. Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow. Cancer Res. 67: 10112-10116. (Pubitemid 350070781)
44. Ponomaryov, T., A. Peled, I. Petit, R. S. Taichman, L. Habler, J. Sandbank, F. Arenzana-Seisdedos, A. Magerus, A. Caruz, N. Fujii, et al. 2000. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J. Clin. Invest. 106: 1331-1339.
45. Peggs, K. S., K. Thomson, D. P. Hart, J. Geary, E. C. Morris, K. Yong, A. H. Goldstone, D. C. Linch, and S. Mackinnon. 2004. Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood 103: 1548-1556.